UBS Group’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,954
| Closed | -$19K | – | 10190 |
|
|
2022
Q3 | $19K | Buy |
1,954
+25
| +1% | +$243 | ﹤0.01% | 6401 |
|
|
2022
Q2 | $19K | Buy |
1,929
+970
| +101% | +$9.55K | ﹤0.01% | 5939 |
|
|
2022
Q1 | $9K | Sell |
959
-1,649
| -63% | -$15.5K | ﹤0.01% | 7558 |
|
|
2021
Q4 | $26K | Buy |
2,608
+1,135
| +77% | +$11.3K | ﹤0.01% | 6454 |
|
|
2021
Q3 | $14K | Buy |
+1,473
| New | +$14K | ﹤0.01% | 6484 |
|